Stock Screener App

Frei -

Installieren

59.88

4.82% 3.0014

Monopar Therapeutics Inc (MNPR)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	26.55% 4.0931	3.2343	3.2218	11.07	1.5749
Operating Income/Loss	26.55% -4.0931	-3.2343	-3.2218	-11.07	-1.5749
Income/Loss From Continuing Operations Before Tax	40.11% -3.4376	-2.4535	-2.625	-10.92	-1.3043
Income/Loss From Continuing Operations After Tax	40.11% -3.4376	-2.4535	-2.625	-10.93	-1.3043
Net Income/Loss	40.11% -3.4376	-2.4535	-2.625	-10.93	-1.3043
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.80% 7.1238	6.9981	6.9874	0.3709	3.5204
Basic Earnings Per Share	37.14% -0.48	-0.35	-0.38	-2.75	-0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$28.50

0.78%

RPRX

$50.76

2.57%

BNTX

$92.69

3.01%

INSM

$138.73

1.11%

RVMD

$147.88

0.02%

ONC

$305.60

2.86%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters